Does UnitedHealthcare Cover Jardiance?
The verdict
Covered on most plans
Yes — UnitedHealthcare covers Jardiance for type 2 diabetes, heart failure, and CKD across commercial, ACA, Medicare, and Medicaid, managed through OptumRx, broadly on-formulary. On Medicare, prior authorization is essentially zero: nationally 0% of Medicare plans require PA and only 0.1% require step therapy for Jardiance (MMIT, as of Aug 8, 2025). On UHC commercial plans, the OptumRx Step Therapy program commonly requires a metformin-first step (38.9% of commercial plans nationally — MMIT, Aug 8, 2025). The 2026 IRA negotiated Maximum Fair Price is $197 per 30-day supply. The $2,100 annual Part D cap limits Medicare exposure.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.
Key facts
On Medicare, Jardiance is one of the lowest-UM branded drugs: nationally 0% of Medicare Part D plans require prior authorization and only 0.1% require step therapy (MMIT, as of Aug 8, 2025).
MMIT via GoodRx (as of Aug 8, 2025)
The 2026 IRA Maximum Fair Price for Jardiance is $197 per 30-day supply — a 66% reduction from the prior list price of approximately $573; all UHC Part D plans must apply this price effective January 1, 2026.
CMS Medicare Drug Price Negotiation Program, 2026 MFP
Nationally 38.9% of commercial plans require step therapy for Jardiance (usually metformin-first), per MMIT as of Aug 8, 2025 — the OptumRx Step Therapy program is the operative tool on UHC commercial plans.
MMIT via GoodRx (as of Aug 8, 2025)
Medicare vs. commercial coverage
Whether UnitedHealthcare covers Jardiance depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Jardiance is covered on UnitedHealthcare's Medicare Advantage and Part D plans (Advantage 3-Tier PDL), typically as a Tier 3 preferred brand. Prior authorization and step therapy on Medicare are near-zero for Jardiance: nationally 0% of Medicare Part D plans require PA and only 0.1% require step therapy (MMIT, as of Aug 8, 2025). As a Part D sponsor, UnitedHealthcare must apply the IRA negotiated Maximum Fair Price of $197 per 30-day supply, effective January 1, 2026 — a 66% reduction from the prior list price of approximately $573. The 2026 Part D $2,100 annual out-of-pocket cap limits total exposure. Note: the coinsurance-shift caveat applies — the MFP is a payer-side ceiling, and your actual cost depends on whether your UHC plan uses a fixed copay or coinsurance. LIS/Extra Help enrollees pay $0–$12.65 per month. Medicare beneficiaries cannot use the Boehringer Ingelheim commercial savings card.
Commercial / Employer
Group & marketplace plans
UnitedHealthcare's commercial and ACA plans, managed through OptumRx, broadly cover Jardiance — nationally 99.7% of commercial plans and 99.9% of ACA plans cover it (MMIT, Aug 8, 2025). The operative commercial hook is the OptumRx Step Therapy program: nationally 38.9% of commercial plans require a metformin-first step for Jardiance (MMIT, Aug 8, 2025). This means many UHC commercial and employer plans require documented metformin use before Jardiance is approved. Your prescriber should document prior metformin use at the maximum tolerated dose or a clinical contraindication (for example, renal impairment or intolerance) to resolve the step-therapy requirement. ACA plans may also carry a step-therapy requirement (nationally 27.7%). UHC Community Plan Medicaid covers Jardiance with nominal cost-share ($0–$10 typical); prior authorization and metformin-first step therapy are common in Medicaid (nationally 25.5% PA, 22.9% step — MMIT, Aug 8, 2025). Verify your state's Preferred Drug List. The Boehringer Ingelheim savings card (~$10 per fill) is available for commercially insured patients not enrolled in a government program. No generic empagliflozin is currently available.
The 3 boxes you must tick to get approved
Commercial plans that will consider Jardiance require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Jardiance actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $600 or more per 30-day supply at retail pharmacy for brand Jardiance (pharmacy-variable estimate). No generic empagliflozin is currently available.
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D/Advantage (UHC): Tier 3 cost-share; IRA Maximum Fair Price $197 per 30-day supply effective January 1, 2026; $2,100 annual out-of-pocket cap; LIS/Extra Help $0–$12.65 per month. Medicaid: $0–$10 typical. Commercial: Boehringer Ingelheim savings card ~$10 per fill (commercially insured, non-government patients). All figures are estimates — verify with your specific UHC plan.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates. Your actual cost depends on your UHC plan's tier structure, deductible status, and benefit phase. The MFP of $197 is a payer-side ceiling — your copay depends on whether your UHC plan uses a fixed copay or coinsurance. Medicare beneficiaries cannot use the Boehringer Ingelheim commercial savings card. Confirm cost-share on the OptumRx formulary for your specific UHC plan.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Jardiance on the OptumRx or UHC plan formulary tool
Visit myuhc.com or the OptumRx formulary search for your 2026 plan. Search for Jardiance or empagliflozin to confirm the tier, any prior authorization or step-therapy requirements from the OptumRx Step Therapy program, and your estimated cost-share. Confirm whether your plan uses a fixed copay or coinsurance for the Tier 3 preferred brand.
- 2
Ask your prescriber to document metformin history if on commercial or Medicaid
If you are on a UHC commercial, employer, ACA, or Medicaid plan, a metformin-first step-therapy requirement via OptumRx is common for Jardiance. Ask your prescriber to document prior metformin use (dose, duration, and reason for stopping or contraindication such as renal impairment) with the prescription to efficiently resolve the step-therapy requirement.
- 3
Call UHC member services to confirm tier, step-therapy, and deductible
Call the number on the back of your UHC ID card. Ask: (1) Which tier is Jardiance on my OptumRx formulary? (2) Does the OptumRx Step Therapy program apply to Jardiance on my plan? (3) Is prior authorization required? (4) Has my annual deductible been met? (5) Does my plan use a fixed copay or coinsurance for Tier 3? Have your plan ID and Jardiance dosage ready.
Options if UnitedHealthcare won't cover Jardiance
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Farxiga (dapagliflozin) or generic dapagliflozin
Another SGLT2 inhibitor for T2D, heart failure, and CKD. Generic dapagliflozin is already available and may offer a lower tier cost-share than brand Jardiance on UHC plans. The 2026 IRA negotiated price for Farxiga is $178.50 per 30-day supply. Note: the OptumRx commercial step-therapy rate for Farxiga is even higher (45.8%) than for Jardiance. Discuss with your prescriber whether dapagliflozin or empagliflozin better fits your clinical needs.
Januvia (sitagliptin) or generic sitagliptin
A DPP-4 inhibitor for type 2 diabetes. Generic sitagliptin launched May 2026 (Sandoz), offering significantly lower cost. The 2026 IRA negotiated price for Januvia is $113 per 30-day supply. DPP-4s lack the cardiovascular and kidney benefits of SGLT2s — discuss clinical appropriateness with your prescriber.
Metformin (generic)
First-line oral diabetes medication; Tier 1 at approximately $4 per month cash price. If the OptumRx Step Therapy program requires metformin first, your prescriber will document this before approving Jardiance.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — UnitedHealthcare covers Jardiance for type 2 diabetes, heart failure, and CKD across commercial, ACA, Medicare, and Medicaid via OptumRx, typically as a Tier 3 preferred brand. On Medicare, prior authorization is essentially zero (0% PA, 0.1% step nationally — MMIT, Aug 8, 2025). On UHC commercial plans, the OptumRx Step Therapy program commonly requires metformin-first (38.9% of commercial plans nationally). The 2026 IRA negotiated price is $197 per 30-day supply.
CMS negotiated a Jardiance Maximum Fair Price of $197 per 30-day supply, effective January 1, 2026 — a 66% reduction from the prior list price of approximately $573. All UHC Part D plans must apply this price. The MFP is a payer-side ceiling — your actual copay depends on your plan's tier structure and whether the plan uses a fixed copay or coinsurance. The $2,100 annual Part D out-of-pocket cap limits your worst-case Medicare exposure.
On UHC Medicare plans, metformin-first step therapy is not expected — nationally 0% of Medicare plans require PA and 0.1% require step therapy for Jardiance (MMIT, Aug 8, 2025). On UHC commercial plans, the OptumRx Step Therapy program commonly requires a metformin-first step for Jardiance (38.9% of commercial plans nationally — MMIT, Aug 8, 2025). Your prescriber can resolve this by documenting prior metformin use at the maximum tolerated dose or a clinical contraindication. Verify your specific OptumRx plan.
Both Jardiance (empagliflozin) and Farxiga (dapagliflozin) are SGLT2 inhibitors covered by UHC via OptumRx. The 2026 IRA price is $197 for Jardiance versus $178.50 for Farxiga. Generic dapagliflozin (Farxiga's generic) is available, while no empagliflozin generic exists yet. The commercial step-therapy rate is slightly lower for Jardiance (38.9%) than for Farxiga (45.8%). Clinical differences in cardiovascular and kidney trial data should guide your prescriber's choice.
Only if you have a UHC commercial plan — not Medicare or Medicaid. The Boehringer Ingelheim savings card (~$10 per fill) is available for commercially insured patients not enrolled in any government health program. If you have UHC Medicare Part D, Medicare Advantage, or a UHC Medicaid plan, you cannot use the savings card. LIS/Extra Help enrollees on Medicare may pay $0–$12.65 per month through the federal subsidy instead.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.